Evolus, Inc. SEC filings EOLS

Evolus, Inc. has 557 filings in SEC EDGAR's recent list, going back to Feb 27, 2013. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Evolus, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
4 Insider transaction Sep 4, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 2, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 31, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Aug 4, 2026 Aug 3, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jul 8, 2026 Jul 7, 2026
EFFECT Filing Jun 12, 2026 —
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 11, 2026
CORRESP Letter to the SEC Jun 10, 2026 —
UPLOAD Letter from the SEC Jun 10, 2026 —
S-3 Shelf registration Jun 5, 2026 —
10-Q Quarterly report May 4, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 4, 2026 May 4, 2026
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 11, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 20, 2026 Mar 20, 2026
4 Insider transaction Mar 20, 2026 Mar 20, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
8-K Current report
Officer or director change
Mar 13, 2026 Mar 13, 2026
S-8 Employee stock plan registration Mar 3, 2026 —
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Material agreement, Results of operations, New debt
Mar 3, 2026 Mar 3, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Results of operations
Jan 9, 2026 Jan 9, 2026
4 Insider transaction Dec 29, 2025 Dec 22, 2025
4 Insider transaction Dec 29, 2025 Dec 22, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
4 Insider transaction Oct 9, 2025 Sep 8, 2025
3 Initial insider ownership Oct 9, 2025 Sep 8, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 8, 2025 Sep 8, 2025
4 Insider transaction Aug 26, 2025 Aug 22, 2025
4 Insider transaction Aug 18, 2025 Aug 15, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 18, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change
Aug 5, 2025 Aug 1, 2025
4 Insider transaction Jun 16, 2025 Jun 13, 2025
144 Notice of proposed sale Jun 16, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
4 Insider transaction Jun 10, 2025 Jun 9, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 6, 2025 Jun 5, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
May 27, 2025 May 23, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
4 Insider transaction May 14, 2025 May 12, 2025
4 Insider transaction May 14, 2025 May 13, 2025
4 Insider transaction May 14, 2025 May 12, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure
May 5, 2025 May 5, 2025
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
4 Insider transaction Mar 28, 2025 Mar 27, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 14, 2025 Mar 12, 2025
144 Notice of proposed sale Mar 12, 2025 —
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
4 Insider transaction Mar 11, 2025 Mar 7, 2025
S-8 Employee stock plan registration Mar 4, 2025 —
10-K Annual report Mar 4, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 4, 2025 Mar 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2025 —
8-K Current report
Results of operations
Jan 21, 2025 Jan 21, 2025
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
UPLOAD Letter from the SEC Dec 18, 2024 —
CORRESP Letter to the SEC Dec 12, 2024 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
UPLOAD Letter from the SEC Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
S-8 Employee stock plan registration Nov 6, 2024 —
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
4 Insider transaction Sep 6, 2024 Sep 6, 2024
4 Insider transaction Sep 4, 2024 Aug 30, 2024
10-Q Quarterly report Jul 31, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 31, 2024 Jul 31, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
3 Initial insider ownership Jul 3, 2024 Jul 1, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 1, 2024 Jul 1, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2024 Jun 6, 2024
4 Insider transaction Jun 6, 2024 Jun 4, 2024
144 Notice of proposed sale Jun 6, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
144 Notice of proposed sale Jun 5, 2024 —
144 Notice of proposed sale Jun 4, 2024 —
144 Notice of proposed sale Jun 3, 2024 —
4 Insider transaction May 15, 2024 May 13, 2024
4 Insider transaction May 15, 2024 May 13, 2024
4 Insider transaction May 14, 2024 May 10, 2024
4 Insider transaction May 14, 2024 May 10, 2024
4 Insider transaction May 14, 2024 May 10, 2024
144 Notice of proposed sale May 14, 2024 —
144 Notice of proposed sale May 13, 2024 —
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
8-K Current report
Officer or director change
Apr 3, 2024 Apr 2, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
8-K Current report
Material agreement
Mar 13, 2024 Mar 11, 2024
424B5 Prospectus supplement Mar 11, 2024 —
S-8 Employee stock plan registration Mar 7, 2024 —
10-K Annual report Mar 7, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 7, 2024 Mar 7, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
4 Insider transaction Feb 2, 2024 Jan 30, 2024
144 Notice of proposed sale Jan 30, 2024 —
SC 13G Ownership over 5% (passive) Jan 29, 2024 —
8-K Current report
Results of operations
Jan 16, 2024 Jan 16, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Dec 20, 2023 Dec 20, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
144 Notice of proposed sale Dec 6, 2023 —
SC 13G Ownership over 5% (passive) Nov 27, 2023 —
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
4 Insider transaction Oct 18, 2023 Oct 16, 2023
SC 13G/A Amended ownership over 5% (passive) Oct 18, 2023 —
S-8 Employee stock plan registration Oct 6, 2023 —
SC 13G/A Amended ownership over 5% (passive) Oct 4, 2023 —
4 Insider transaction Sep 8, 2023 Sep 6, 2023
4 Insider transaction Aug 23, 2023 Aug 21, 2023
3 Initial insider ownership Aug 23, 2023 Aug 21, 2023
4 Insider transaction Aug 16, 2023 Aug 14, 2023
4 Insider transaction Aug 16, 2023 Aug 14, 2023
4 Insider transaction Aug 16, 2023 Aug 14, 2023
4 Insider transaction Aug 15, 2023 Aug 11, 2023
4 Insider transaction Aug 15, 2023 Aug 11, 2023
4 Insider transaction Aug 15, 2023 Aug 11, 2023
SC 13D/A Amended ownership over 5% (active) Aug 14, 2023 —
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Results of operations
Jul 27, 2023 Jul 27, 2023
SC 13G Ownership over 5% (passive) Jun 16, 2023 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 14, 2023 Jun 9, 2023
424B5 Prospectus supplement Jun 9, 2023 —
EFFECT Filing Jun 8, 2023 —
CORRESP Letter to the SEC Jun 7, 2023 —
S-3/A Filing Jun 7, 2023 —
4 Insider transaction May 9, 2023 May 8, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EOLS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Newport Beach, CA
SEC filer status
Accelerated filer
SEC CIK
1570562
Former names
Evolus, Inc. (until Nov 4, 2026)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.